imiquimod has been researched along with nanaomycin e in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Funatsu, T; Harada, Y; Ikoma, K; Matsui, Y; Misawa, T; Nakayama, A; Nishida, S; Noguchi, Y; Pan, Y; Saitoh, T; Shirasaki, Y; Sunazuka, T; Takahama, M; Takemura, N; Taura, M | 1 |
1 other study(ies) available for imiquimod and nanaomycin e
Article | Year |
---|---|
Nanaomycin E inhibits NLRP3 inflammasome activation by preventing mitochondrial dysfunction.
Topics: Caspase 1; Imiquimod; Inflammasomes; Interleukin-1beta; Mitochondria; Naphthoquinones; NLR Family, Pyrin Domain-Containing 3 Protein | 2022 |